What antithrombotic therapy should I use for my patient with atrial fibrillation who underwent percutaneous coronary intervention or had an acute coronary syndrome?

[摘要] Double therapy (ie, an oral anticoagulant and a P2Y12 inhibitor such as clopidogrel) is reasonable for most patients, ie, those with average risk of ischemia, elevated risk of bleeding, or both. However, in certain patients, particularly those with atrial fibrillation who undergo percutaneous coronary intervention or those at higher risk of ischemia, triple therapy (ie, an oral anticoagulant, a P2Y12 inhibitor, and low-dose aspirin) may be reasonable initially.

[学科分类] 卫生学